Axela Acquires Xceed Molecular to Bolster Biomarker Discovery Business
July 27, 2010
Axela Acquires Xceed Molecular to Bolster Biomarker Discovery Business
Axela to date has focused on providing protein analysis tools and services, and the addition of Xceed's Ziplex System for gene expression analysis will support its ambitions to speed the validation and clinical application of DNA, RNA, and protein biomarkers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Axela Taps Digilab to Market Array Analysis Systems to US Customers
August 2, 2011 / BioArray News - Axela Partners with OvaGene to Commercialize Ovarian Cancer PGx Test
August 21, 2012 / BioArray News - Axela Acquires Xceed Molecular
July 26, 2010 / GenomeWeb Daily News - Two Hospitals Collaborate to Assess Axela Breast Cancer Assay
July 12, 2012 / GenomeWeb Daily News - Isogen to Distribute Axela Platforms
May 17, 2012 / GenomeWeb Daily News